CD44 and breast cancer: Therefore, we tested the impact of the exogenous LIF, and it altered the morphology of breast cancer cells to a cancer stem-cell-like phenotype, which was explained by the enhanced expression levels of dedifferentiation markers CD24−/CD44+.